Dustin Smith, Ph.D.
About Dustin Smith, Ph.D.
Dustin Smith, Ph.D., serves as the Executive Director and CDx Strategy Lead at Amunix Pharmaceuticals and has held various leadership roles at Genentech. He specializes in developing personalized healthcare strategies and has a strong background in biochemistry and molecular biology.
Current Role at Amunix Pharmaceuticals
Dustin Smith, Ph.D. serves as the Executive Director, CDx Strategy Lead at Amunix Pharmaceuticals. He has held this position since 2021, contributing to the development of companion diagnostics strategies. His role focuses on aligning diagnostic solutions with therapeutic advancements to enhance patient outcomes.
Experience at Genentech
Dustin Smith has been with Genentech since 2012, where he currently works as the Senior Project Leader for Companion Diagnostic Development. In this role, he has been integral in advancing cancer immunotherapy initiatives. He also leads the CDx Cancer Immunotherapy Franchise, a position he has held since 2018, emphasizing personalized healthcare strategies.
Previous Positions at Crescendo Bioscience
Prior to his current roles, Dustin Smith worked at Crescendo Bioscience in various capacities. He served as Project Manager from 2009 to 2012, then transitioned to Associate Director of Program Management for a brief period in 2012. He also held the position of Research Program Manager for one year in 2008, gaining valuable experience in program management and research.
Educational Background
Dustin Smith earned his Bachelor of Science in Biochemistry from the University of Oklahoma, where he studied from 1995 to 1999. He furthered his education at the University of Oklahoma Health Sciences Center, obtaining a Ph.D. in Biochemistry and Molecular Biology from 1999 to 2004. His academic background supports his expertise in personalized healthcare and product development.
Focus on Personalized Healthcare
Dustin Smith has a strong focus on developing personalized healthcare strategies aimed at improving patient care. His passion for driving new product development addresses unmet medical needs, reflecting his commitment to advancing healthcare solutions through innovative diagnostics and therapies.